Details for Patent: 11,884,696
✉ Email this page to a colleague
Which drugs does patent 11,884,696 protect, and when does it expire?
Patent 11,884,696 protects ZURZUVAE and is included in one NDA.
This patent has thirty-six patent family members in twenty-two countries.
Drugs Protected by US Patent 11,884,696
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biogen Inc | ZURZUVAE | zuranolone | CAPSULE;ORAL | 217369-001 | Oct 31, 2023 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING POSTPARTUM DEPRESSION | ⤷ Try a Trial | ||||
| Biogen Inc | ZURZUVAE | zuranolone | CAPSULE;ORAL | 217369-002 | Oct 31, 2023 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING POSTPARTUM DEPRESSION | ⤷ Try a Trial | ||||
| Biogen Inc | ZURZUVAE | zuranolone | CAPSULE;ORAL | 217369-003 | Oct 31, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING POSTPARTUM DEPRESSION | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,884,696
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 109393 | ⤷ Try a Trial | |||
| Argentina | 125320 | ⤷ Try a Trial | |||
| Argentina | 125321 | ⤷ Try a Trial | |||
| Australia | 2017315682 | ⤷ Try a Trial | |||
| Australia | 2022200811 | ⤷ Try a Trial | |||
| Australia | 2024200732 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
